1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARCTURUS THERAPEUTICS HOLDINGS INC
Arcturus Therapeutics Holdings Inc
XNAS: ARCT

Arcturus Therapeutics Holdings Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities ...

Read More
8.62 -0.01 (-0.12%)
64.34% Fall from 52W High
159.4K
XNAS Volume

XNAS 04 May, 2026 1:46 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Arcturus Therapeutics Holdings Inc is on 12 May 2026 for the purpose of Arcturus Therapeutics Holdings Inc First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
24.3 / 100
Momentum Score
Technically Neutral
43.0 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
23
1Yr Price target upside is 170%
10 analysts

11

S

13

W

4

O

0

T

SWOT Analysis

Arcturus Therapeutics Holdings Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..